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Background: Studies have suggested that selective microbial targets prevail in the fecal microbiota of infants with
eczema. This study evaluated the composition of fecal microbiota of infants who developed eczema in the first
5 years of life and compared these with those of healthy controls.
Findings: Children who developed eczema in the first 2 years, those with eczema at 5 years of age and healthy
controls were selected from the placebo arm of a birth cohort of at-risk infants participating in a randomized
double-blind trial on the protective effects of supplemental probiotics in early life on allergic outcomes. Molecular
evaluation of fecal microbiota were conducted using Fluorescence In Situ Hybridization-Flow Cytometry (FISH-FC)
for fecal samples collected. Longitudinal analysis of fecal microbiota composition at three days, one and three months
and one year of life revealed higher abundance of Enterobacteriaceae [coefficient (B): 1.081, 95% CI: 0.229-1.933,
adj p = 0.014] and Clostridium perfringens [coefficient (B): 0.521, 95% CI: 0.556-0.988, adj p = 0.03] in those who
developed eczema in the first 2 years life. In those with eczema at 5 years of age, a lower abundance of Bifidobacterium
was observed [coefficient (B): −27.635, 95% CI: −50.040 - -5.231, adj p = 0.018].
Conclusions: The differences in infant fecal microbiota observed in eczema subjects in this study support the notion
that relative abundance of selective microbial targets may contribute to the subsequent development of eczema in
childhood.Findings
Background
Allergic diseases, such as eczema, are chronic inflamma-
tory disorders with increasing global trends [1]. Intes-
tinal microbiota play a role in the regulation of innate
and adaptive immunity [2] and has been implicated in
the development of allergy diseases [3]. The composition
of fecal microbiota of infants and young children with
eczema differ from healthy children [4]. This study aims
to evaluate and monitor the composition, maturation,
development of fecal microbiota at 4 times points of an
at risk birth cohort in the first year of life, and compare
these findings in relation to the development of eczema
at 2 and 5 years of age with those of healthy controls.* Correspondence: paeleebw@nus.edu.sg
1Department of Paediatrics, Yong Loo Lin School of Medicine, National
University of Singapore, Singapore, Singapore
Full list of author information is available at the end of the article
© 2014 Yap et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Methods
Subjects with eczema and healthy controls were selected
from the placebo arm of a birth cohort of at-risk infants
participating in a randomized double-blind trial on the
protective effects of supplemental probiotics in early life on
allergic outcomes [5]. Subjects who developed eczema in
the first 2 years (eczema, n = 28; healthy, n = 32), and those
with eczema at 5 years of age (eczema, n = 15 [persistent
from 2 years: n = 11; new cases: n = 4]; healthy, n = 19)
were studied. Thirteen controls were excluded in the 5 year
analysis because they developed allergen sensitization,
rhinitis and wheeze at 5 years of age (Figure 1). Informed
consent was obtained from all families. The study was ap-
proved by the hospital’s institutional ethical review board
(Ref Code: 2006/00008). Stool samples were collected at 4
time points (3 days, 1, 3 and 12 months of age) as previ-
ously described [6] There were missing stool samples in
2% to 25% of subjects at different time points, but these
were not different between cases and controls. Subjects. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Flowchart of study subjects showing the progress of eczema development in the first 2 years and at 5 years of age. *Thirteen
controls were excluded in the 5 year analysis because they developed allergen sensitization, rhinitis and wheeze at 5 years of age.
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subclassified into atopic (positive skin prick test to com-
mon allergens) eczema (2 yrs: n = 13; 5 yrs: n = 12) and
non-atopic eczema (2 yrs: n = 15; 5 yrs: n = 3).
Molecular evaluation of fecal microbiota was conducted
using/harnessing whole-cell-based detection approach
based on Fluorescence In Situ Hybridization combined
with Flow Cytometry (FISH-FC) for fecal samples collected
at 3 days, 1, 3 and 12 months. 16S rRNA probes wereTable 1 Demographic characteristics of children with eczema b






Male 14 (50) 15 (46
Female 14 (50) 17 (53
Mode of delivery (%)
Lower segment caesarean section 7 (25) 9 (28
Vaginal delivery 21 (75) 23 (71
Feeding history from birth to month 6 (%)
Breastfeeding and formula feeding 21 (75) 26 (81
Total formula feeding 7 (25) 6 (18selected to target and quantify the Eubacterium rectale-
Clostridium coccoides group (Erec 482), Clostridium leptum
subgroup (Clep 866 and the corresponding competitor
probes), Bacteroides-Prevotella group (Bac 303), Bifidobac-
terium genus (Bif 164), Atopobium group (Ato 291), Lacto-
bacilli-Enterococci group (Lab 158), Enterobacteriaceae
family (Enter 1432), Clostridium perfringens (Cperf191),
Clostridium difficile (Cdif198) and Escherichia coli (Eco
1531) as previously described [7].y 2 years and at 5 years of age and their healthy controls








.9) 0.809 6 (40) 9 (47.4) 0.667
.1) 9 (60) 10 (52.6)
.1) 0.785 4 (26.7) 4 (21.1) 1
.9) 11 (73.3) 15 (78.9)
.3) 0.558 11 (73.3) 16 (84.2) 0.672
.7) 4 (26.7) 3 (15.8)
Table 2 Relative abundance of fecal bacterial groups for children with eczema by 2 years of age and their
healthy controls
Healthy Eczema by 2 years of age
Time points Bacterial group n Mean (SD) n Mean (SD)
3 day E.rectale - C. coccoides 21 0.27 (1.139) 19 ND
Clostridium leptum 21 3.08 (9.155) 19 ND
Bacteriodes-Prevotella 21 5.56 (11.654) 19 6.88 (19.386)
Bifidobacterium 21 29.35 (36.872) 19 15.88 (30.175)
Atopobium 21 0.44 (0.801) 19 0.86 (3.555)
Lactobacilli–Enterococci 21 3.22 (8.631) 19 0.49 (1.370)
Enterobacteriaceae 21 26.22 (35.55) 19 41.64 (37.819)
Clostridium perfringens 12 2.05 (7.093) 16 2.99 (8.137)
Clostridium difficile 12 ND 16 0.66 (2.365)
E.coli 11 14.17 (29.862) 16 34.98 (40.363)
1 month E.rectale–C. coccoides 23 0.29 (0.589) 19 6.65 (18.510)
Clostridium leptum 23 ND 19 2.47 (9.339)
Bacteriodes-Prevotella 23 1.65 (3.309) 19 6.01 (16.408)
Bifidobacterium 23 41.27 (38.514) 19 28.38 (33.945)
Atopobium 23 6.52 (12.635) 19 2.32 (6.41)
Lactobacilli–Enterococci 23 2.74 (7.265) 19 7.98 (15.762)
Enterobacteriaceae 23 15.63 (23.726) 19 20.1 (23.837)
Clostridium perfringens 15 0.19 (0.751) 18 0.55 (1.482)
Clostridium difficile 15 ND 18 ND
E.coli 15 9.01 (18.952) 18 3.62 (4.631)
3 month E.rectale–C. coccoides 28 5.45 (10.551) 24 7.43 (13.389)
Clostridium leptum 28 0.46 (1.590) 24 0.01 (0.059)
Bacteriodes-Prevotella 28 3.53 (7.845) 24 3.32 (5.126)
Bifidobacterium 28 55.86 (32.344) 24 54.21 (33.827)
Atopobium 28 10.19 (16.06) 24 3.72 (7.037)
Lactobacilli–Enterococci 28 2.77 (3.121) 24 2.62 (3.404)
Enterobacteriaceae 28 3.8 (7.222) 24 6.51 (10.024)
Clostridium perfringens 17 0.72 (1.547) 20 2.26 (6.246)
Clostridium difficile 17 ND 20 ND
E.coli 17 1.16 (2.725) 20 4.26 (10.987)
1 year E.rectale–C. coccoides 27 30.40 (18.445) 24 31.25 (16.0.42)
Clostridium leptum 27 4.22 (7.022) 24 1.33 (3.047)
Bacteriodes–Prevotella 27 10.05 (10.082) 24 4.175 (6.049)
Bifidobacterium 27 28.88 (23.227) 24 27.92 (25.196)
Atopobium 27 5.91 (8.639) 24 5.05 (9.337)
Lactobacilli–Enterococci 27 1.57 (3.437) 24 1.45 (4.99)
Enterobacteriaceae 27 0.10 (0.3) 24 1.65 (3.162)
Clostridium perfringens 18 ND 24 0.30 (1.457)
Clostridium difficile 18 ND 22 0.07 (0.328)
E.coli 18 0.05 (0.129) 23 0.83 (2.22)
ND, not detected.
Yap et al. BMC Research Notes 2014, 7:166 Page 3 of 6
http://www.biomedcentral.com/1756-0500/7/166
Table 3 Relative abundance of fecal bacterial groups for children with eczema at 5 years of age and their
healthy controls
Healthy Eczema at 5 years of age
Time points Bacterial group n Mean (SD) n Mean (SD)
3 day E.rectale–C. coccoides 10 ND 9 ND
Clostridium leptum 10 2.7 (8.526) 9 3.74 (11.217)
Bacteriodes-Prevotella 10 10.32 (15.729) 9 7.49 (19.590)
Bifidobacterium 10 21.65 (33.2) 9 24.45 (34.194)
Atopobium 10 0.21 (0.439) 9 0.12 (0.229)
Lactobacilli–Enterococci 10 5.48 (12.272) 9 0.64 (1.307)
Enterobacteriaceae 10 47.73 (41.03) 9 30.89 (39.958)
Clostridium perfringens 7 ND 5 ND
Clostridium difficile 7 ND 5 ND
E.coli 7 21.87 (35.99) 5 20.36 (39.873)
1 month E.rectale–C. coccoides 13 0.32 (0.670) 10 0.74 (1.687)
Clostridium leptum 13 ND 10 4.06 (12.829)
Bacteriodes-Prevotella 13 2.92 (4.008) 10 6.56 (20.824)
Bifidobacterium 13 48.29 (36.270) 10 21.28 (28.332)
Atopobium 13 5.15 (9.403) 10 6.01 (12.463)
Lactobacilli–Enterococci 13 1.91 (3.987) 10 5.77 (18.246)
Enterobacteriaceae 13 19.54 (28.826) 10 18.19 (20.289)
Clostridium perfringens 10 0.29 (0.92) 6 ND
Clostridium difficile 10 ND 6 ND
E.coli 10 11.62 (22.528) 6 5.27 (7.354)
3 month E.rectale–C. coccoides 16 4.83 (10.187) 12 7.67 (14.804)
Clostridium leptum 16 0.17 (0.688) 12 0.2 (0.678)
Bacteriodes-Prevotella 16 2.83 (5.904) 12 6.42 (9.913)
Bifidobacterium 16 55.21 (33.0) 12 42.557 (35.960)
Atopobium 16 12.73 (19.887) 12 5.96 (9.282)
Lactobacilli–Enterococci 16 2.79 (3.085) 12 3.07 (3.726)
Enterobacteriaceae 16 4.28 (6.634) 12 10.94 (14.169)
Clostridium perfringens 12 0.98 (1.791) 7 6.50 (9.55)
Clostridium difficile 12 ND 7 ND
E.coli 12 1.64 (3.152) 7 6.83 (13.998)
1 year E.rectale–C. coccoides 15 28.20 (19.361) 12 29.78 (15.534)
Clostridium leptum 15 3.54 (7.102) 12 1.84 (2.359)
Bacteriodes-Prevotella 15 9.22 (10.450) 12 4.86 (8.232)
Bifidobacterium 15 37.97 (23.939) 12 18.88 (24.0)
Atopobium 15 6.45 (9.575) 12 4.40 (5.199)
Lactobacilli–Enterococci 15 1.59 (3.724) 12 3.29 (6.987)
Enterobacteriaceae 15 0.04 (0.152) 12 1.59 (3.133)
Clostridium perfringens 12 ND 9 ND
Clostridium difficile 12 ND 7 0.22 (0.582)
E.coli 12 0.07 (0.155) 8 1.78 (3.521)
ND, not detected.
Yap et al. BMC Research Notes 2014, 7:166 Page 4 of 6
http://www.biomedcentral.com/1756-0500/7/166
Figure 2 Longitudinal comparison of the fecal microbiota of
children with and without eczema. Linear mixed model analysis
of fecal microbiota of children with eczema in (a) the first 2 years of
life and (b) at 5 years of age, compared to healthy controls. Only
microbial targets with statistically significant difference between
eczema and controls are shown.
Yap et al. BMC Research Notes 2014, 7:166 Page 5 of 6
http://www.biomedcentral.com/1756-0500/7/166Linear mixed model was used to evaluate the longitu-
dinal differences (i.e. 4 time points) of bacterial targets
with adjustments for gender, mode of delivery, breast-
feeding up to 6 months and comorbidities (rhinitis and
wheeze) [8].
Results
The demographic characteristics and data showing the
relative abundance of fecal bacterial groups for children
who developed eczema by 2 and at 5 years of age and
their healthy controls are summarized in Tables 1, 2 and
3 respectively. Longitudinal monitoring of the dynamics
of intestinal bacterial colonization over 4 time points
(3 days, one month, three months and one year of life)
in the first year of life showed higher relative abundance
of Enterobacteriaceae [coefficient (B): 1.081, 95% CI: 0.229-
1.933, adj p = 0.014] in children with eczema by 2 years of
age, and Clostridium perfringens [coefficient (B): 0.521,
95% CI: 0.556-0.988, adj p = 0.03] in eczema n = 28) by
2 years of age compared to healthy controls (n = 32)
(Table 2 and Figure 2a).
Sub-group analysis of atopic eczema (n = 13) and non-
atopic eczema (n = 15) cases with onset in first 2 years of
life yielded similar results, with higher abundance of En-
terobacteriaceae compared to controls [atopic eczema:
coefficient (B): 0.949, 95% CI: 0.214-1.683, adj p = 0.013;
non atopic eczema: coefficient (B): 1.119, 95% CI: 0.136-
2.102, adj p = 0.027], and Clostridium perfringens for
non-atopic eczema only [coefficient (B): 0.713, 95% CI:
0.124-1.303, adj p = 0.022]. This analysis was also carried
out with controls (n = 19) who were healthy all the way
till 5 years of age (that is did not develop eczema after
the age of 2 years), and similar findings were observed
(data not shown).
For atopic eczema at 5 years old, a lower relative
abundance of Bifidobacterium was found in cases (n =
15) compared to healthy controls (n = 19) [coefficient
(B): −27.635, 95% CI: −50.040 - -5.231, adj p = 0.018]
(Table 3 and Figure 2b).
Discussion
In this study significant differences in fecal microbiota
signatures analyzed at 4 times points in the first year of
life were observed in infants who developed eczema in
the first 5 years of life. These data suggests that specific
microbial signatures appearing in early life might be pre-
dictive of eczema. Previous studies have also compared
infant microbiota at more than one time point in infancy
[3,9]. Sjögren et al. reported lower prevalence of lactoba-
cilli group I and Bifidobacterium adolescentis at 1 week
after birth for atopic dermatitis compared to non-allergic
controls, but no significant differences were found for the
other time points i.e. 1 month and 2 months [3]. In an-
other study, reduced microbial diversity at 1 month and12 months were associated with the presence of serum
specific IgE, while allergic rhinitis group at school age
showed less microbial diversity at 1 month [9]. Instead of
making comparisons between single time points, our
study utilized linear mixed model analysis to enabled com-
parisons over 4 time points in the first year of life. Our
findings indicate that a consistent pattern in profile of
fecal microbiota over the first year was associated with de-
velopment of childhood eczema.
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tional studies, where increased numbers of bacterium from
Clostridium cluster IV and XIVa have been reported. These
clusters of Clostridium are normally found in abundance
in the adult intestine [10,11]. Although we did not find any
difference for Clostridium cluster IV and XIVa in our study
but we did observe an increase in Clostridium perfringens
in children with eczema. This findings was supported by a
recent study where Clostridium cluster I was associated
with higher risk of developing atopic dermatitis [12].
An increased abundance of Enterobacteriaceae has
also been observed in atopic subjects [13]. We have also
previously shown by 16S rRNA pyrosequencing in this
same cohort that fecal Enterobacteriaceae was more
abundant at the age of 1 month in eczema compared to
match controls [14]. Higher abundance of Enterobacteri-
aceae has been reported to be associated with intestinal
inflammation (dextran sodium sulfate induced colitis),
suggesting that Enterobacteriaceae may be responsible
for promoting immune dysregulation [15].
The reduced abundance of Bifidobacterium in eczema
compared to healthy controls has been observed in several
other studies [3,7], and is associated with an increased risk
of atopic dermatitis [16]. We did not observe reduced
abundance of Bifidobacterium for eczema in the first
2 years of life compared to healthy controls. However, in
subjects whose onset of eczema occurred by the age of
2 years (n = 28), we found that in those with eczema per-
sistent till 5 years (n = 11) had lower abundances of Bifido-
bacterium compared with those with transient eczema
(resolved before 5 years) (n = 17) as well as healthy con-
trols, but these differences did reach statistical significance
(p = 0.099) (data not shown). These observed differences,
occurring in early life, in the maturation and development
of the infant gut microbiota between subjects with atopic
dermatitis and healthy controls suggests that the gut
microbiota may influence immune system development
[17] and contribute to disease severity [2].
In conclusion, this prospective study which profiled the
dynamics of intestinal bacterial colonization over infancy
supports the notion that relative abundance of selective
microbial targets may contribute to the subsequent devel-
opment of eczema in childhood.
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